
Life sciences firm Danaher's DHR.N shares rise 2.7% to $190 premarket
DHR posts Q1 adj. profit of $1.88 per share, beating analysts estimates of $1.64 per share, according to the data compiled by LSEG
Company posts Q1 revenue of $5.70 billion vs estimates of $5.59 billion
Company anticipates that Q2 revenue will grow low-single digits year-over-year
DHR expects annual profit in the range of $7.60 to $7.75 per share vs estimates of $7.68 per share
Company expects annual revenue to grow 3%
Company expects incurring incremental tariff costs in 2025 of several hundred millions of dollars
As of last close, DHR fell 19.4% YTD